Clinical Trial

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

The study met its primary endpoint with no procedure or device related serious adverse events reportedRUTHERFORD, N.J., Feb. 04, 2025…

11 months ago

Medexus and Ontario’s Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 4, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed listing…

11 months ago

ScienceMedia® Set to Launch SMi Engage™ at 2025 SCOPE Summit

Patient-centric video training solution builds trust and simplifies clinical trial enrollment, engagement, and retention SAN DIEGO, Feb. 4, 2025 /PRNewswire/…

11 months ago

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ --…

11 months ago

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy, Medidata is transforming how industries are empowering patients with new cure and care…

11 months ago

TriSalus Life Sciences Announces Key Appointments to Board of Directors

HealthCare Industry Veterans William Valle and Gary Gordon, M.D. add Strategic Expertise in Medical Devices, Reimbursement, and Pancreatic CancersDENVER--(BUSINESS WIRE)--TriSalus…

11 months ago

Hemostemix Expands to the Dominican Republic

Calgary, Alberta--(Newsfile Corp. - February 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")…

11 months ago

Moore Market analysis: Zero Candida potential market will reach over $2 Billion by 2030

According to the report: up to 75% of women will have at least one vaginal yeast infection in their life…

11 months ago

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor

HOPE has announced plans to assemble a best-in-class global network of interventional psychiatry clinics combining ketamine treatment with transcranial magnetic…

11 months ago

HeartX Cardiovascular Accelerator Seeks Innovative Early-Stage Companies for 2025 Program

BENTONVILLE, Ark., Feb. 3, 2025 /PRNewswire/ -- HealthTech Arkansas and MedAxiom have launched year four of HeartX, a cardiovascular-focused healthcare…

11 months ago